SNDX Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for SNDX is 0.03 -- better than just 8.72% of US stocks.
• With a price/sales ratio of 127.45, Syndax Pharmaceuticals Inc has a higher such ratio than 98.39% of stocks in our set.
• As for revenue growth, note that SNDX's revenue has grown -32.8% over the past 12 months; that beats the revenue growth of just 5.87% of US companies in our set.
• Stocks that are quantitatively similar to SNDX, based on their financial statements, market capitalization, and price volatility, are FATE, RCUS, ALPN, FIXX, and INO.
• SNDX's SEC filings can be seen here. And to visit Syndax Pharmaceuticals Inc's official web site, go to www.syndax.com.